AI in pharma marketing: unlock more value

In this excerpt from an interview by Paul Simms, Anthill CTO Tor Kristensen explains an overall approach to introducing generative AI in pharma marketing.

Instead of upending all existing systems and content, Tor details Anthill’s method which is to use generative AI in pharma to unlock the full potential of existing investments.

This approach to generative AI in pharma enables companies to work in entirely new ways but in a way that’s easily understandable by everyone and fits the specific needs of a regulated industry.

To learn what’s possible, discover Anthill’s AI marketing services:

#GenerativeAIPharma #GenerativeAIHealthcare #PharmaAI #AIPharma #PharmaMarketingAI #HealthcareMarketingAI